Period:
Draw Mode:
| Volume | 77,757 |
|
|||||
| News | - | ||||||
| Day High | 0.07 | Low High |
|||||
| Day Low | 0.0655 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vivos Inc (QB) | RDGL | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.00285 | -4.04% | 0.06765 | 12:43:36 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.07 | 0.0655 | 0.07 | 0.0705 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6 | 77,757 | $ 0.068078 | $ 5,294 | - | 0.04 - 0.1195 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:43:36 | 50,000 | $ 0.06765 | USD |
Vivos Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 25.01M | 369.38M | 295.92M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vivos (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RDGL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.071 | 0.071 | 0.0621 | 0.068654 | 237,424 | -0.00335 | -4.72% |
| 1 Month | 0.0624 | 0.075 | 0.0555 | 0.066362 | 329,916 | 0.00525 | 8.41% |
| 3 Months | 0.0549 | 0.08 | 0.0481 | 0.0606072 | 303,621 | 0.01275 | 23.22% |
| 6 Months | 0.07 | 0.1195 | 0.0481 | 0.0680634 | 471,374 | -0.00235 | -3.36% |
| 1 Year | 0.051 | 0.1195 | 0.04 | 0.0624361 | 458,197 | 0.01665 | 32.65% |
| 3 Years | 0.0251 | 0.31 | 0.01875 | 0.0977424 | 1,236,795 | 0.04255 | 169.52% |
| 5 Years | 0.02955 | 0.31 | 0.0024 | 0.0403313 | 2,405,491 | 0.0381 | 128.93% |
Vivos (QB) Description
| Vivos Inc, developed an yttrium-90 brachytherapy device to combat cancer in humans and animals. Testing at Washington State University, the University of Missouri and our pilot veterinary clinic has verified the safety to the patient, the therapist and the family members. IsoPet is commercially available for animal therapy and can deliver very high doses to solid tumors with a single same day therapy. Pre-clinical testing is in progress to generate key data for an Investigational Devise Exemption to the FDA to begin human clinical trials. |